着床前診断の世界市場分析:タイプ別(染色体異常、HLAタイピング、X連鎖疾患、性別の選択、遺伝的障害)、用途別(幹細胞治療用胚HLAタイピング、IVF予後、遅発性遺伝的疾患、遺伝病)、セグメント予測、 – 2024...市場調査レポートについてご紹介

【英文タイトル】Preimplantation Genetic Diagnosis Market Analysis By Type (Chromosomal Abnormalities, HLA typing, X-linked Diseases, Gender Selection, & Genetic Disorders), By Application (Embryo HLA Typing for Stem Cell Therapy, IVF Prognosis, Late Onset Genetic Disorders, Inherited Genetic Diseases) And Segment Forecasts To 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Preimplantation Genetic Diagnosis Industry Outlook
3.1 Market segmentation
3.2 Market size and growth prospects, 2013 – 2024
3.3 Preimplantation genetic diagnosis market dynamics
3.3.1 Market driver analysis
3.3.1.1 Rising incidences of genetic diseases
3.3.1.2 Demand for healthy and successful embryo implantation
3.3.1.3 Increase in rate of infertility
3.3.2 Market restraint analysis
3.3.2.1 Ethical and legal constraints
3.4 Key opportunities prioritized, 2015
3.5 Industry analysis – Porter’s
3.6 Preimplantation genetic diagnosis PESTEL Analysis
Chapter 4 Preimplantation Genetic Diagnosis Type Outlook
4.1 Global preimplantation genetic diagnosis revenue share, by type, 2015 & 2024
4.2 PGD for chromosomal abnormalities
4.2.1 PGD for chromosomal abnormalities market, 2013 – 2024 (USD Million)
4.3 PGD for HLA typing
4.3.1 PGD for HLA typing market, 2013 – 2024 (USD Million)
4.4 PGD for X-linked diseases
4.4.1 PGD for X-linked diseases market, 2013 – 2024 (USD Million)
4.5 PGD for gender selection
4.5.1 PGD for gender selection market, 2013 – 2024 (USD Million)
4.6 PGD for Other genetic disorders
4.6.1 PGD for other genetic disorders market, 2013 – 2024 (USD Million)
Chapter 5 Preimplantation Genetic Diagnosis Application Outlook
5.1 Global preimplantation genetic diagnosis revenue share, by application, 2015 & 2024
5.2 Identification of HLA-compatible embryos for stem cell therapy
5.2.1 HLA-compatible embryos for stem cell therapy market, 2013 – 2024 (USD Million)
5.3 Prognosis improvement in in-vitro fertilization patient
5.3.1 IVF prognosis market, 2013 – 2024 (USD Million)
5.4 Late onset genetic disorders
5.4.1 Late onset genetic disorders market, 2013 – 2024 (USD Million)
5.5 Inherited genetic disease
5.5.1 Inherited genetic disease market, 2013 – 2024 (USD Million)
5.6 Others PGD applications
5.6.1 Others PGD applications market, 2013 – 2024 (USD Million)
Chapter 6 Preimplantation Genetic Diagnosis Regional Outlook
6.1 Preimplantation genetic diagnosis revenue share, by region, 2015 & 2024
6.2 North America
6.2.1 North America preimplantation genetic diagnosis market, 2013 – 2024 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. preimplantation genetic diagnosis market, 2013 – 2024 (USD Million)
6.2.3 Canada
6.2.3.1 Canada preimplantation genetic diagnosis market, 2013 – 2024 (USD Million)
6.3 Europe
6.3.1 Europe preimplantation genetic diagnosis market, 2013 – 2024 (USD Million)
6.3.2 Germany
6.3.2.1 Germany preimplantation genetic diagnosis market, 2013 – 2024 (USD Million)
6.3.3 UK
6.3.3.1 UK preimplantation genetic diagnosis market, 2013 – 2024 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific preimplantation genetic diagnosis market, 2013 – 2024 (USD Million)
6.4.2 Japan
6.4.2.1 Japan preimplantation genetic diagnosis market, 2013 – 2024 (USD Million)
6.4.3 China
6.4.3.1 China preimplantation genetic diagnosis market, 2013 – 2024 (USD Million)
6.5 Latin America
6.5.1 Latin America preimplantation genetic diagnosis market, 2013 – 2024 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil preimplantation genetic diagnosis market, 2013 – 2024 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico preimplantation genetic diagnosis market, 2013 – 2024 (USD Million)
6.6 MEA
6.6.1 MEA preimplantation genetic diagnosis market, 2013 – 2024 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa preimplantation genetic diagnosis market, 2013 – 2024 (USD Million)
Chapter 7 Competitive Landscape
7.1 F. Hoffmann-La Roche AG
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2 Genea
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.3 Quest Diagnostics
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4 Illumina Inc.
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.4.4 Strategic Initiatives
7.5 Natera
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6 Genesis Genetics LLC
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.7 Reprogenetics LLC
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
7.7.4 Strategic Initiatives
7.8 Laboratory Corporation of America Holdings (LabCorp)
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Product Benchmarking
7.8.4 Strategic Initiatives
7.9 Reproductive Genetics Institute Inc.
7.9.1 Company Overview
7.9.2 Product Benchmarking
7.9.3 Strategic Initiatives
7.10 California Pacific Medical Center
7.10.1 Company Overview
7.10.2 Financial Performance
7.10.3 Product Benchmarking
7.10.4 Strategic Initiatives


【レポート販売概要】

■ タイトル:着床前診断の世界市場分析:タイプ別(染色体異常、HLAタイピング、X連鎖疾患、性別の選択、遺伝的障害)、用途別(幹細胞治療用胚HLAタイピング、IVF予後、遅発性遺伝的疾患、遺伝病)、セグメント予測、 – 2024
■ 英文:Preimplantation Genetic Diagnosis Market Analysis By Type (Chromosomal Abnormalities, HLA typing, X-linked Diseases, Gender Selection, & Genetic Disorders), By Application (Embryo HLA Typing for Stem Cell Therapy, IVF Prognosis, Late Onset Genetic Disorders, Inherited Genetic Diseases) And Segment Forecasts To 2024
■ 発行日:2016年9月7日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707700
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。